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During purification of recombinant Cdc6 expressed in yeast, we found that Cdc6 inter-
acts with the critical cell cycle, cyclin-dependent protein kinase Cdc28. Cdc6 and Cdc28
can be coimmunoprecipitated from extracts, Cdc6 is retained on the Cdc28-binding
matrix p13-agarose, and Cdc28 is retained on an affinity column charged with bacterially
produced Cdc6. Cdc6, which is a phosphoprotein in vivo, contains five Cdc28 consensus
sites and is a substrate of the Cdc28 kinase in vitro. Cdc6 also inhibits Cdc28 histone Hi
kinase activity. Strikingly, Cdc6 interacts preferentially with B-type cyclin/Cdc28 com-
plexes and not Cln/Cdc28 in log-phase cells. However, Cdc6 does not associate with
Cdc28 when cells are blocked at the restrictive temperature in a cdc34 mutant, a point in
the cell cycle when the B-type cyclin/Cdc28 inhibitor p4Osicl accumulates and purified
p4Osicl inhibits the Cdc6/Cdc28 interaction. Deletion of the Cdc28 interaction domain
from Cdc6 yields a protein that cannot support growth. However, when overproduced,
the mutant protein can support growth. Furthermore, whereas overproduction of wild-
type Cdc6 leads to growth inhibition and bud hyperpolarization, overproduction of the
mutant protein supports growth at normal rates with normal morphology. Thus, the
interaction may have a role in the essential function of Cdc6 in initiation and in
restraining mitosis until replication is complete.
INTRODUCTION
The yeast Cdc6 protein seems to be essential for cell
cycle-specific activation of DNA replication origins.
Early studies showed that cdc6 mutants arrest at the
nonpermissive temperature with 1N DNA and one
large bud (Hartwell, 1976). Reciprocal shifts suggested
a block in initiation, because cdc6 mutants remain
sensitive to hydroxyurea, which inhibits elongation,
after shift-down from the nonpermissive temperature
and are insensitive to a temperature block after release
from hydroxyurea arrest (Hartwell, 1976). Plasmids
containing a single origin of DNA replication are un-
stable in cdc6 mutants, but this plasmid-loss pheno-
type is suppressed by the presence of multiple origins
on a single plasmid, suggesting a direct interaction
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between Cdc6 and yeast autonomously replicating se-
quences (ARS) (Hogan and Koshland, 1992). Further-
more, analysis of replication intermediates formed at
the nonpermissive temperature in a cdc6 mutant show
that origin firing is defective (Liang et al., 1995). The
Cdc6 protein produced in baculovirus-infected insect
cells has been shown to coimmunoprecipitate with
yeast ORC, the six protein complex that binds specif-
ically to ARSs and is required for the initiation of
DNA replication (Bell and Stillman, 1992; Bell et al.,
1993; Liang et al., 1995). In fact, Cdc6 is highly homol-
ogous to the largest subunit of ORC, ORC1 (Bell et al.,
1995). Recent evidence suggests that Cdc6 associates
with ORC late in mitosis or early in Gl and remains
associated with ORC during Gi, but it is not associ-
ated with ORC after origin firing for the duration of S
phase, G2, and early M (Diffley and Cocker, 1992;
Diffley et al., 1994; Rowley et al., 1995; Cocker et al.,
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1996). Expression of the CDC6 gene is periodic, mRNA
levels accumulating transiently in late Gl and then
again in late M or early Gi (Zhou and Jong, 1990;
Bueno and Russell, 1992; Piatti et al., 1995). Unlike
other replication proteins, the Cdc6 protein seems to
be unstable, and its intracellular levels mirror mRNA
accumulation (Piatti et al., 1995). If expression of Cdc6
is turned off in growing cells, they fail to initiate DNA
replication upon depletion of Cdc6 but undergo an
aberrant mitosis, segregating unreplicated chromo-
somes (Piatti et al., 1995). A homologue of CDC6,
called cdc18+, exists in Schizosaccaromyces pombe (Kelly
et al., 1993). cdcl8 mutants are defective in the initia-
tion of DNA replication; furthermore, cdc18 mutants,
like cdc6, fail to arrest in mitosis but divide with un-
replicated chromosomes. In summary, Cdc6 has the
properties of a prime regulator of replication initia-
tion, but molecular evidence for its precise mechanism
of action is very limited.
An unexplained property of Cdc6 is that CDC6 res-
cues mitotic catastrophe in S. pombe cdc2 weel mutants,
and overproduction under a GAL promoter leads to a
G2 delay in Saccaromyces cerevisiae (Bueno and Russell,
1992). This observation has been used to suggest that
Cdc6 is part of a signal that restrains mitosis until S
phase is complete. It has recently been shown that the
G2 delay observed in S. cerevisiae upon overexpression
of Cdc6 requires active Clb5,6 and that constitutive
overproduction of Clb5 leads to an identical G2 delay
as overproduction of Cdc6 (Basco et al., 1995). Clb5,6 is
required for entry into S phase and, interestingly, also
perhaps for preventing re-replication in the G2 phase
of the cell cycle (Epstein and Cross, 1992; Richardson
et al., 1992; Kuhne and Linder, 1993; Schwob and
Nasmyth, 1993; Dahmann et al., 1995). Overproduc-
tion of CLB5 also leads to constitutive overproduction
of Cdc6 mRNA, which might account for the similar
phenotypes. However, the phenotype also might re-
flect a direct interaction. Either explanation is consis-
tent with the observation that cdc6ts mutants are sup-
pressed by overproduction of CLB5 (Basco et al., 1995).
Recently we have found that Cdc6 interacts with
Cdc28, that it is specific for B-cyclin/Cdc28 complexes
but not Cln/Cdc28 complexes, and that the associa-
tion is cell cycle-regulated. Deletion of the Cdc28 in-
teraction domain has multiple effects on the cell cycle.
We propose that this association is important for the
regulation, resulting in the correct ordering of DNA
replication and mitosis in the cell cycle.
MATERIALS AND METHODS
Strains
Glutathione-S-transferase (GST) and fusion proteins GST-Cdc6 and
GST-Cdc6/Kll4E were expressed in BJ2168 (a prcl-407 prbl-1122
pep4-3 leu2 trpl ura 3-52) and RJD635 (a ura3 leu2 trpl pep4::TRP1
cdc28::CDC28-HA::TRP1 barl::LEU2), which contains hemaggluti-
nin-tagged Cdc28. GST and GST-Cdc6 were also expressed in strain
RJD561 (a cdc28-4 ura3 leu2 pep4::TRP1).
Tagged cyclins for kinase and inhibition assays were prepared
from YMT263 (a cln2::CLN2-HA-LEU2 ade2-1 trpl-1 leu2-3, 112 ura3
GAL+), K3819 (a ura3::ADH-HA-CLB5-URA ade2-1 trp-1 leu2-3, 112
GAL'), and YMG17 (a leu2-3, 112::GAL-CLB2-HA-LEU2 ade2-1
trpl-1 ura3 GAL') (Peter and Herskowitz, 1994).
Extracts containing tagged cyclins for bincing experiments were
prepared from RJD934 (a canl-100, leu2-3, 112, his3-11, 15, trpl-1,
ura3-1, ade2-1, pep4::TRP1, leu2::GAL-CLN2-HA::LEU2::URA3),
K3819, and JCY61. Strain JCY61 was prepared by crossing K3819
with RJD668 (a leu2, trpl, ura3, pep::TRP1, cdc34-2), sporulating, and
selecting for segregants that were prototrophic for uracil and tem-
perature-sensitive for growth. (All RJD strains were the gift of Ray
Deshaies, California Institute of Technology, Pasadena, CA.)
Complementation experiments were performed with K4055 (a
leu2-3, canl-100, ade2-1, GAL, CDC6::hisGURA3hisG, trpl-1::TRP1
MET-CDC6) with URA3 looped out (Piatti et al., 1995), in which the
only copy of CDC6 is controlled by the methionine-repressible
MET3 promoter. Incubation of this strain in 2mM methionine yields
a conditional null.
Plasmids
Plasmids for the expression of GST fusion proteins in yeast were
prepared as follows: YGp1O, a yeast vector containing the GAL1,10
promoter, was prepared by cloning an EcoRI fragment containing
the entire GALL,10 promoter into the EcoRI site of YEp352 (Hill et al.,
1986) with the BamHI site in the promoter cassette proximal to the
polylinker. YGpKTU6, encoding GST-Cdc6, was generated in two
steps. CDC6 was first amplified from the PstI site to the end of the
gene (Zhou et al., 1989), and the resulting PstI-HindIII fragment was
cloned into the same sites in YGp1O, generating YGplO-PH6. The N
terminus of the fusion protein was created by amplifying the bac-
terial GST fusion protein (described below) from the start codon
through the PstI site. The resulting SacI-PstI fragment was cloned
into the same sites of YGplO-PH6, resulting in YGpKTU6. YGpME6,
encoding GST-Cdc6/K114E, was generated by replacing a PstI frag-
ment of YGpKTU6, containing both gene and vector sequence, with
a similar fragment in which lysine 114 had been mutated to gluta-
mate. pRD56a contained GST alone, driven by the GALl,10 pro-
moter, and was provided by Ray Deshaies.
Plasmids for the expression of CDC6 and cdc6AN, a mutant miss-
ing the N-terminal 47 amino acids, from the GALl,10 promoter were
generated as follows: YGp618, containing the CDC6 gene, was gen-
erated by cloning CDC6 from the SspI site upstream of the transla-
tional start site to the SpeI site downstream of the stop codon into
YGp1O. pSEl9, containing cdc6AN, was generated by cutting
YGp618 with BamHI and PstI, which cuts CDC6 at residue 48, and
replacing the fragment with an oligonucleotide cassette comprising
SE27 and SE28, allowing for expression from residue 48 of CDC6.
Plasmids for the expression of CDC6 and cdc6AN from the natural
promoter were prepared as follows: the CDC6 promoter from the
XhoI site to the translation start site was amplified by polymerase
chain reaction (PCR) with oligos SE23 and SE24. SacI and BamHI
sites were introduced into the 5' and 3' ends, respectively. This
promoter was cloned into pBluescript SK(-), generating pSE14. The
full-length CDC6 open reading frame was amplified by PCR with
oligonucleotides SE35 and SE37, which introduced BamHI and NdeI
sites upstream of the coding sequence and a HindIl site down-
stream. This fragment was cloned into the BamHI and HindIII sites
of pSE14 to generate pSE20. For expression in yeast, pSE20 was cut
with SacI and HindIII, and the resulting fragment containing both
promoter and coding region was cloned into the same sites in
pRS315 (Sikorski and Hieter, 1989) to generate pSE26. cdc6AN was
amplified by PCR with oligos SE36 and SE37, which introduced
BamHI and NdeI sites just upstream of the PstI site and a HindIII site
downstream of the stop codon. This fragment was cloned into the
BamHI and HindIII sites of pSE14 to generate pSE21. pSE21 was cut
with SacI and HindIII and cloned into pRS315 to generate pSE27.
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Oligonucleotides
The following oligonucleotides were used in this work: SE23 GC-
GAAACCTAGAGGCTTTCTCGAGGCAAAAAT-TlTTCCAA, SE24
TCAATAGTACCATATACGTTCATGTCAGCTATACCAA, SE27
GATCCGGCATATGGGCGGCCTGCA, SE28 GGCCGCCCATAT-
GCCG, SE35 GGAGGATCCGGAGGCCATATGTCAGCTATAC-
CAATAACT, SE36 GGAGGATCCGGAGGCCATATGCTGCAG-
TTTGGCTCAC, and SE37 GGCCAAAGCTTCATTGTACCCC-
ACCTC.
Expression and Purification of GST and Fusion
Proteins from Yeast
Proteins were expressed in the yeast strains BJ2168 and RJD635 as
follows: cells were grown to a density of 2 x 107 cells/ml in minimal
medium containing raffinose, induced with 2% galactose, and har-
vested after 4 h. Extracts were prepared by glass bead lysis in buffer
A (50 mM Tris-HCl, pH 7.5, 500 mM NaCl, 0.2% Nonidet P-40, 10%
glycerol, 1.5 mM dithiothreitol [DTT], 2 mM EDTA, and 1 mM
ethylene glycol bis(,-aminoethyl)ether-N,N,N',N'-tetra-acetic acid
[EGTA]) with protease inhibitors (60 ,ug/ml AEBSF [4-(2-aminoeth-
yl)-benzenesulfonylfluoride, hydrochloride], 160 jig/ml benzami-
dine, 1 ,tg/ml aprotinin, 1 ,zg/ml leupeptin, and 1 ,tg/ml antipain),
and cleared by spinning at 35,000 rpm for 20 min at 4°C. Extract was
incubated with glutathione-agarose beads at a ratio of 200 mg of
extract per milliliter of matrix for 3 h at 4°C with gentle agitation.
Beads were washed extensively with buffer A and then with buffer
B (buffer A with 0.15 M salt in place of 0.5 M salt). Protein was
eluted with 5 mM reduced glutathione in buffer B by incubating
overnight at 4°C. Expression from RJD561 was as described above,
except that cells were grown at 23°C.
Expression and Purification of bGST-Cdc6
Proteins and Charging of Beads with the
Recombinant Proteins
All vectors for bacterial expression were based on pGEX-2T. bGST-
CDC6 contains GST fused to the CDC6 open reading frame. GST-NB
contains GST fused to CDC6 from the first ATG to the BglII site at
residue 190. GST-NP contains GST fused to CDC6 from the first
ATG to the PstI site at residue 48. GST-BE contains GST fused to a
C-terminal fragment beginning at the BglII site at residue 190 and
ending at the natural termination codon. Proteins were expressed
by growing Escherichia coli DH5a cells containing these vectors to an
OD600 of 0.6, inducing with 1 mM isopropyl thiogalactoside (IPTG)
and shifting to 30'C, and harvesting after 4 h. Extracts were pre-
pared by lysing cells in buffer C (50 mM Tris-HCl, pH 7.2, 50 mM
NaCl, 10 mM DTT, 10% glycerol, 0.5% NP-40, and 0.5 mM EDTA)
with protease inhibitors (as above). For each fusion protein, beads
were prepared by incubating extract (3-5 mg of protein) of cells
expressing fusion protein with 60 ,ul of glutathione-agarose beads
for 1 h and then washing in lysis buffer.
Preparation of Hemagglutinin Epitope-
tagged Cyclins
For preparation of extract for either kinase or binding assays, strains
were grown as follows: RJD635, YMT263, and K3819 were grown in
YPD to a density of 4 x 10' cells/ml and harvested. YMG17 cells
were grown in YPRaffinose; expression of HA-Clb2 was induced
with 2% galactose at a density of 2 x 107 cells/ml and harvested
after 2h. RJD934 cells were grown to saturation in YPD, inoculated
into YPGalactose at a dilution of 1:500, grown for 16 h, and har-
vested. Extracts were prepared by glass bead lysis in YEB (25 mM
4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid [HEPES], pH
7.4, 150 mM NaCl, 0.2% NP-40, 5% glycerol, 0.5 mM DTT, 2 mM
EDTA, 5 mM NaF, and protease inhibitors, as described).
Preparation of Cdc6 Antibodies
Cdc6 antibody was generated to the C-terminal 330 amino acids of
CDC6 fused to TrpE and expressed in bacteria. Antibodies to TrpE
were removed by passing serum over a TrpE affinity column.
Immunoprecipitations
12CA5 antibody was incubated for 1 h with extract prepared in YEB
at a ratio of 1-5 ,lg of antibody per milligram of extract. One
hundred microliters of 100 mg/ml protein A-Sepharose slurry was
added and incubated for an additional hour. Beads were washed
extensively with YEB before use in kinase assays.
Protein Kinase Assays
Reactions for immunoprecipitated kinases and kinases copurifying
with GST-Cdc6 were performed in 50 mM Tris-HCl, pH 7.5, 2 mM
DTT, 10 mM MgCl2, 1 mM ATP, and 500 cpm/pmol [y-32P]ATP for
30 min at 37°C. Samples were electrophoresed on a 10% denaturing
gel and autoradiographed. Protein kinase A (PKA) was ordered
from New England Biolabs (Beverly, MA), and assays were per-
formed per manufacturer's instructions.
Complementation of a MET3-CDC6 Strain by CDC6
and cdc6AN
Plasmids expressing GAL-CDC6, GAL-cdc6AN, CDC6, or cdcAN
were transformed into K4055 (see MATERIALS AND METHODS
for description of plasmids and strain), and transformants were
selected on medium lacking methionine and uracil (YEp352 series,
GALI, 10 promoter) or lacking methionine and leucine (pRS315
series, CDC6 promoter). Colonies were purified on the same me-
dium and then tested for their ability to grow on solid medium
containing 2 mM methionine. The GAL1,10 promoter series was
tested on medium containing glucose only, raffinose only, glucose
and galactose, and raffinose and galactose as carbon sources. The
CDC6 promoter series was plated on medium containing glucose.
All sugars were present at a concentration of 2%. Cells were grown
on plates for 3 d, at which time both colonies and cells were
photographed.
RESULTS
Cdc6 and Cdc28 Protein Interact
To study the molecular mechanisms by which Cdc6
participates in DNA replication, Cdc6 was purified
from yeast as a GST-Cdc6 fusion protein (Figure 1A).
The purified protein was assessed for biochemical ac-
tivities that might be associated with a protein with
the properties defined by genetic and molecular bio-
logical analysis of the CDC6 gene. In particular,
ATPase activity was investigated, but no ATPase ac-
tivity could be demonstrated as intrinsic to the pro-
tein. Others have reported that an ATPase associates
with bGST-Cdc6 purified from E. coli (Zwerschke et al.,
1994), and this discrepancy will be discussed else-
where (Jong and Campbell, unpublished data). Given
the pivotal role that Cdc6 is likely to play in the
initiation of DNA replication, we next examined
whether Cdc6 might interact with the Cdc28 protein
kinase, the action of which is necessary for the firing of
replication origins (Epstein and Cross, 1992; Richard-
son et al., 1992; Kuhne and Linder, 1993; Schwob and
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Nasmyth, 1993). As shown in the protein blot in Fig-
ure 1B, Cdc28 is indeed associated with the purified,
recombinant Cdc6 protein. When glutathione-agarose
charged with GST-Cdc6 is washed with buffer con-
taining 1.5 M NaCl, bound Cdc28 can still be detected
to the same degree (Jong and Campbell, unpublished
data). Thus, the proteins seem to interact with very
high affinity.
Because Cdc6 is overproduced in the experiments
shown in Figure 1B, it was possible that the ob-
served association was an artifact of overproduc-
tion. To show that Cdc6 interacts with Cdc28 at
physiological concentrations and to confirm that en-
dogenous Cdc6, as well as the yGST-Cdc6 fusion
protein, binds to Cdc28, the association was inves-
tigated in wild-type yeast cells, that is, cells carrying
neither tagged nor overproduced Cdc6 or Cdc28.
Cdc28 was enriched on p13 agarose beads, and the
Cdc28/p13 beads were assessed for bound Cdc6 by
polyclonal Cdc6 antibody. As shown in Figure 2,
Cdc6 is associated with Cdc28.
To demonstrate that copurification shown in Fig-
ure 1 was due to interaction between the two pro-
teins, we coexpressed hemagglutinin epitope-
tagged Cdc28 (HA-Cdc28) and yGST-Cdc6 in yeast.
yGST-Cdc6 was found in immunoprecipitates of
HA-Cdc28 prepared with the anti-epitope antibody
12CA5 (Figure 3A), but not in 12CA5 immunopre-
cipitates in which tagged Cdc28 was absent (Figure
3B). Similarly, HA-Cdc28 was present in glutathio-
ne-agarose-purified yGST-Cdc6, but not in yGST
preparations (Figure 3C). In a separate set of exper-
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Figure 1. Cdc28 copurifies with Cdc6. (A) Electrophoretic analysis
of yGST and yGST-Cdc6 expressed in yeast and affinity-purified on
glutathione-agarose. Glutathione-S-transferase (GST) and GST-
tagged Cdc6 were expressed in yeast and purified as described (see
MATERIALS AND METHODS). Purified yGST-Cdc6 (100 ng) was
electrophoresed, stained with silver (lane 1), and analyzed by im-
munoblotting with Cdc6 antibody (lane 2) and GST antibody (lane
3). Cdc6 antibody is described in MATERIALS AND METHODS.
(B) Cdc28 copurifies with yGST-Cdc6. Purified yGST and yGST-
Cdc6 protein were electrophoresed, blotted, and probed with Cdc28
antibody (gift of R. Deshaies, California Institute of Technology,
Pasadena, CA). Lane 1, 100 ,ug of extract; lane 2, 100 ng of yGST;
lane 3, 100 ng of yGST-Cdc6.
1 jig Figure 2. Association of en-
Cdc6 p13 Agarose dogenous Cdc6 with endoge-
nous Cdc28. BJ2168 extract (10
1 2 3 4 mg) was prepared, and Cdc28
was precipitated by incubating
66 - extract with 20 plJ of p13 aga-
rose, followed by extensive
washing. Protein was eluted,
electrophoresed, and immuno-
45 blotted with Cdc6 antibody.
Lane 1, 1 ,ug of conventionally
purified, nontagged Cdc6 (to be
described elsewhere); lanes 2-4,
31 _ p13 affinity-purified Cdc28. Im-munoblots were prepared as
follows: lanes 1 and 2 were
probed with Cdc6 antibody; lane 3 was probed with Cdc6 antibody,
but secondary antibody was omitted; lane 4 was probed with non-
specific antiserum. Cdc6 was not present on control beads (no p13)
incubated with extract (our unpublished observations).
iments, we had observed that mutation of lysine
114 to glutamate generated a Cdc6 protein that
failed to complement a cdc6A mutant (Jong and
Campbell, unpublished data). We asked whether
this defect in growth was correlated with a lack of
Cdc28 binding and observed that the binding of
Cdc28 to the mutant protein was equivalent to wild
type (Figure 3A). Therefore, using diverse method-
ologies, we observed that the Cdc6 and Cdc28
proteins can form a stable and specific complex,
although we estimate that only a small fraction of
the total cellular Cdc28 is present in complexes with
Cdc6.
The N-terminal 47 Amino Acids of Cdc6 Are
Necessary and Sufficient for Cdc28 Binding
To identify the region of the Cdc6 protein that is
important for interaction with Cdc28, we performed
a deletion analysis. Full-length and truncated bGST-
Cdc6 proteins were expressed in E. coli (Figure 4A),
purified with glutathione-agarose beads, and incu-
bated with yeast extracts in the presence or absence
of ATP. After extensive washing, the bound proteins
were eluted and analyzed by Western blotting.
Cdc28 present in the yeast extract was clearly re-
tained on the bGST-Cdc6 beads (Figure 4B, lane 1).
This analysis revealed that the N-terminal 47 amino
acids of Cdc6 are sufficient for interaction with
Cdc28 (Figure 4B, lane 7). This region contains sev-
eral Cdc28 recognition sites, two of which overlap a
putative bipartite nuclear localization signal and
one of which is adjacent to a potential PEST se-
quence (Zhou et al., 1989). The 330 amino acid C-
terminal domain did not form a complex with Cdc28
(Figure 4B, lane 3). Interestingly, Cdc28 associated
with the bGST-Cdc6 only in the presence of ATP.
This dependence does not seem to reflect a require-
ment for the Cdc6 nucleotide binding site (Zhou et
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al., 1989), because fusions lacking the nucleotide
binding site (NP) still bind Cdc28. Furthermore,
proteins with a mutation (K114E) in the consensus
nucleotide binding domain (Jong and Campbell, un-
published data) also interact with Cdc28 to the same
extent as wild type. Thus, the role of the ATP bind-
ing site does not seem to be to promote the interac-
tion with Cdc28.
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Figure 3. Association of Cdc28 with Cdc6 evaluated by coexpress-
ing yGST-Cdc6 and HA-Cdc28 in yeast. yGST, yGST-Cdc6/Kll4E,
and yGST-CDC6 were expressed in strain RJD635, containing hem-
agglutinin-tagged Cdc28. GST-Cdc6/K114E was generated by mu-
tating lysine 114, which falls in the putative nucleotide-binding
motif GTGKT, to glutamate. This mutant does not complement a
deletion of cdc6 (Jong and Campbell, unpublished data). Extracts
were prepared, and 1-mg samples were used for 12CA5 immuno-
precipitations and glutathione-agarose purifications, omitting the
elution step. (A) Cdc28 copurifies with yGST-Cdc6. Immunoprecipi-
tates and glutathione-agarose-purified protein were run on 8 and
12% SDS-gels and transferred to Immobilon. The blot of the 8% gel
was probed with GST antibody (top panel), and the blot of the 12%
gel was probed with Cdc28 antibody (bottom panel). Top, lanes 1
and 2, 8% gel, 30 jig of extract; bottom, lanes 1 and 2, 12% gel, 3 ,ug
of extract; lanes 3 and 4, 12CA5 immunoprecipitates; lanes 5 and 6,
glutathione-agarose-bound protein. Odd-numbered lanes, yGST-
Cdc6/K114E; even-numbered lanes, yGST-Cdc6. (B) Anti-GST im-
munoblot showing that GST-Cdc6 is not precipitated by 12CA5
when expressed in a strain lacking HA-tagged Cdc28. Lane 1, 25 ,tg
of extract with GST-Cdc6 expressed in BJ2168; lane 2, 12CA5 im-
munoprecipitation from 2 mg of the same extract. (C) 12CA5 im-
munoblot showing that Cdc28 is only present in glutathione-aga-
rose-purified yGST-Cdc6 and not in purified GST. Shown are, lane
1, purified yGST and, lane 2, purified yGST-Cdc6, as in Figure 3A,
lane 6.
Binding of Cdc6 to Different
Cyclin/Cdc28 Complexes
In S. cerevisiae, the major cell cycle transitions are
accompanied by accumulation of different classes of
cyclins: CLN1-3, non-B-type cyclins present in Gl and
involved in commitment to the cell cycle and budding;
CLB5 and 6, B-type cyclins active at G1/S through G2
and involved in the initiation of DNA replication and
perhaps in prevention of re-replication in S, G2, and
M; and CLB1,2, B-type cyclins active at G2/M and
required for passage through mitosis. Additional B-
type cyclins, CLB3,4, are expressed during S, G2, and
M. Because Cdc6 is required for specific cell cycle
transitions and not continuously during the cell cycle,
one might then expect a specific cyclin class to be
present in the Cdc28/Cdc6 complexes. To test this, we
immobilized yGST-Cdc6 on glutathione beads and
mixed it with extracts expressing either HA-Cln2 or
HA-Clb5. HA-Clb5 was retained on the beads,
whereas HA-Cln2 was not (Figure 5). HA-Clb2, like
HA-Clb5, was also found to interact with yGST-Cdc6in cells coexpressing the two tagged proteins (our
unpublished observations). Therefore, there is specificformation of B-type cyclin/Cdc28/Cdc6 complexes,
suggesting that there is cell cycle-specific binding of
Cdc6 to Cdc28 and not simply nonspecific binding.
Cdc6 Is an In Vitro Substrate of Cdc28 Kinases
Although the stable association does not necessarilyindicate that Cdc6 is a substrate of the kinase, the fact
that there are three potential Cdc28 phosphorylation
sites within the 47 N-terminal amino acids of Cdc6
suggested that Cdc6 may be phosphorylated by Cdc28(Zhou et al., 1989). As shown in Figure 3A, when
affinity-purified yGST-Cdc6 containing Cdc28 was in-
cubated with [,y-32P]ATP, yGST-Cdc6, but not yGST,
was efficiently phosphorylated. To confirm that the
kinase activity was due to Cdc28, we expressed yGST-
Cdc6 and yGST in the temperature-sensitive mutant
cdc28-4. As shown in Figure 6A, phosphorylation of
yGST-Cdc6 purified from the strain was highly ther-
molabile. The levels of cdc28-4 protein in the Cdc6
preparation were equal to or greater than the levels of
Cdc28 present when Cdc6 was purified from wild-
type cells. To confirm that the phosphorylated proteinin Figure 6A was indeed Cdc6, we tested bGST-Cdc6
as a substrate of hemagglutinin epitope (HA)-tagged
Cdc28. HA-Cdc28 was immunoprecipitated from
asynchronously growing yeast and incubated with
bGST or bGST-Cdc6 and [-y-32P]ATP. bGST-Cdc6 was
phosphorylated, but not bGST (Figure 6B). As a pre-liminary assessment of the possible physiological sig-
nificance of Cdc6 phosphorylation, cells were labeled
with 32Pi, and Cdc6 was shown to be a phosphopro-
tein in vivo (Figure 6C). Phosphoamino acid determi-
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nation showed the presence of phosphoserine (our
unpublished observations).
Because yGST-Cdc6 binds preferentially to B-type
cyclin/Cdc28 complexes, it was of interest to test the
specificity of the Cdc28 kinase phosphorylating Cdc6.
12CA5 immunoprecipitates were prepared from
strains carrying HA-tagged Cln2, Clb5, or Clb2 pro-
tein and tested for their ability to phosphorylate
bGST-Cdc6. Because three putative Cdc28 phosphor-
ylation sites and the Cdc28 interaction domain are
located within the first 47 amino acids, bGST-NP, de-
scribed in Figure 3, was tested first as a substrate with
Figure 4. Mapping of the region of Cdc6 required for
binding Cdc28. (A) Schematic of the CDC6 truncations
and summary of binding. Cross-hatched region, GST
tag; vertical black lines, putative Cdc28 phosphoryla-
tion sites; black box, nucleotide binding site. Con-
structs: bGST-Cdc6, GST fused to full-length CDC6;
bGST-NB, GST fused to residues 1-190 of CDC6;
bGST-NP, GST fused to residues 1-47 of CDC6; bGST-
BE, GST fused to residues 191-513 of CDC6. (B) Bind-
ing of bGST-Cdc6 derivatives to Cdc28. bGST-Cdc6
and mutant proteins were expressed in bacteria and
beads bearing 10-20 ,ug of fusion proteins were pre-
pared as described in MATERIALS AND METHODS.
Charged beads were incubated with 11.25 mg of yeast
extract in the presence (odd-numbered lanes) or ab-
sence (even-numbered lanes) of 1 mM ATP. After
extensive washing of beads, protein was eluted and
electrophoresed in SDS, and the presence of Cdc28
was evaluated by immunoblotting with Cdc28 anti-
body. Lane C, 1 ,ug of purified GST-Cdc28 (60 kDa) as
control for Cdc28 antibody; lanes 1 and 2, bGST-Cdc6;
lanes 3 and 4, bGST-BE; lanes 5 and 6, bGST-NB; lanes
7 and 8, bGST-NP; lanes 9 and 10, bGST-Cdc6/Kll4E.
normalized levels of Cln and Clb kinases. It is clear
that bGST-NP is preferentially phosphorylated by B-
type cyclin/Cdc28 kinases (Figure 6D). The phosphor-
ylated bands, labeled bGST-NP, were shown to cross-
react with GST antibody. Because the Cdc6 antibody
was prepared with a fusion protein missing the N-
terminal 190 amino acids, the presence of Cdc6 amino
acids could not be tested directly. Two additional
potential Cdc28 phosphorylation sites are located near
the N terminus of the protein, and therefore bGST-BE
(see Figure 3A) was also tested as a substrate.
bGST-BE is not detectably phosphorylated by any of
Extract for Figure 5. Binding of yGST-Cdc6 to Clb5/Cdc28
incubation and not to Cln2/Cdc28. yGST and yGST-Cdc6
were expressed in yeast as described in MATERI-
Extract yGST yGST-Cdc6 ALS AND METHODS and shown in Figure 1.
1 2 3 4 E 5 6 7 8 9 10 11 12 Cdc6-containing beads were prepared by incubat-
ing extract with glutathione-agarose for 2 h, fol-
- HA-Cln2 lowed by washing, as described for purification of
fusion proteins from yeast. Beads equivalent to 2
mg of extract were then incubated with extracts of
cells expressing HA-tagged Clb5 or HA-tagged
Cln2 and 2 mM ATP (Peter and Herskowitz, 1994).
Extract for Strain RJD934 was used as a source of tagged Cln2.incubation As shown by the 12CA5 Westerns on the left, the
Extract yGST yGST-Cdc6 amount of extract of cells expressing equivalent
----34 --- ---79 12amounts of HA-Cln2 or HA-Clb5 was determined,1 2 3 4 5 6 7 8 9 10 11 12 and the amount of extract incubated with beads
_
_~- HA-CIb5 was adjusted to contain approximately equal levels
of HA-Cln2 (top panel) or HA-Clb5 (bottom pan-
el). For HA-Cln2, four concentrations ranging from
0.08 to 10 mg protein/ml were used for binding;
for HA-Clb5, four concentrations ranging from 0.02 to 2.0 mg protein/ml were used. yGST or yGST-Cdc6 beads were incubated in the diluted
extracts and then washed, and the amount of cyclin retained was determined by immunoblotting. Lanes 1-4 (top and bottom panels), 10 ,ul
of extracts at increasing concentration. Lane E (top panel only) shows an extract identical to lane 4 that was used as positive control for the
HA-Cln2 Western after binding the Cdc6-beads. Lanes 5-8 (top and bottom panels) show tagged cyclin retained by yGST beads incubated
in increasingly concentrated extract; lanes 9-12 (top and bottom panels) show tagged cyclin retained by yGST-Cdc6 beads incubated in
increasingly concentrated extract.
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Figure 6. Cdc6 is a substrate for Cdc28 kinase A B Mock 12CA5
and a phosphoprotein in vivo. (A) Cdc28 puri- bGST bock6 bGST bCdc6fies with and phosphorylates Cdc6. yGST and Cdc2B cdc28-4yGST-Cdc6 were expressed as before and puri- --------1 2 3 4
fied from wild-type (BJ2168) and cdc28-4 yGST yGST-Cdc6 yGST yGST-Cdc6 97 _
(RJD561) strains. Purified proteins were as- 1 2 3 4 5 6 7 8 9 10 11 12 bGST-
sayed for associated kinase activity at 30, 37, 66 _ Cdc6
and 42°C (see MATERIALS AND METHODS). _ yGST-
The products of the kinase assay were run on a Cdc6 _ I_gG
10% polyacrylamide gel containing SDS and 45 *. P40
autoradiographed. Lanes 1-6 show protein pu-
rified from wild-type cells; lanes 7-12 show
protein purified from cdc28-4 cells. Lanes 1-3 yGST 31 _ bGST
and 7-9, 200 ng of yGST; lanes 4-6 and 10-12,
100 ng of yGST-Cdc6. Lanes 1, 4, 7, and 10 were
assayed at 30°C; lanes 2, 5, 8, and 11 were
assayed at 37°C; lanes 3, 6, 9, and 12 were
assayed at 420C. (B) Bacterially produced Cdc6 C DCIn2 CIb5 Cb2is a substrate for Cdc28. bGST and bGST-Cdc6 1 2 3 4 5 6
were expressed in bacteria and purified. Kinase
97
2 4 6
assays were performed with hemagglutinin
epitope-tagged Cdc28 immunoprecipitated 1 2 66 _
from RJD635 extracts with 12CA5 antibody. -1-bGST-BE
Mock immunoprecipitates were prepared with 200_ _
extract lacking epitope-tagged Cdc28. Lanes 1 IgG
and 2 show mock immunoprecipitates pre- 7 45 _
pared with 5 mg of extract; lanes 3 and 4 show bGST-NP
12CA5 immunoprecipitates prepared with 5 - 0
mg of extract. Lanes 1 and 3, 500 ng of bGST; 66 _ 31_
lanes 2 and 4, 500 ng of bGST-Cdc6. The band -. yCdc6
labeled p40 has not been verified as p40s"'. (C)
Cdc6 is phosphorylated in vivo. Log-phase cells
were labeled with inorganic 32p, (Yoon and
Campbell, 1991). Cdc6 immunoprecipitates E s .
were prepared from cell extract. Proteins were 45 &A A
eluted, electrophoresed, and autoradio- 1 2 3
graphed. Lane 1 shows mock immunoprecipi-
tate with nonimmune rabbit serum; lane 2 * * --_ histone Hi
shows Cdc6 immunoprecipitate. Potato acid
phosphatase decreased the label, showing it
was due to phosphorylation (our unpublished observation). (D) The major region phosphorylated in Cdc6 is within the N-terminal 47 amino
acids. The fusion proteins bGST-NP and bGST-BE were purified from bacteria, as from yeast, as described in MATERIALS AND METHODS.
The purity of the proteins was equivalent to that shown in Figure 1. Lanes 1, 3, and 5 indicate bGST-NP as substrate for the indicated kinases.
Lanes 2, 4, and 6 indicate bGST-BE (see Figure 3) as substrate for the indicated kinases. (E) Cdc6 inhibits HA-Clb2/Cdc28 histone HI kinase
activity. yGST-Cdc6 and yGST were prepared as above. HA-Clb2/Cdc28 was immunoprecipitated from 50 ,tg of extract and assayed for
histone HI kinase in the presence of buffer (lane 1), 300 ng of yGST (lane 2), or 300 ng of yGST-Cdc6 (lane 3).
the kinases in our assays (Figure 6D), suggesting that
the major cyclin B/Cdc28 phosphorylation sites are at
the N terminus of Cdc6.
Cdc6 Protein Inhibits HA-Clb2/Cdc28 Kinase
Constitutive expression of CDC6 has been shown to
delay cells in G2 and to cause bud hyperpolarization
(Bueno and Russell, 1992), phenomena that also occur
when the mitotic cyclins are downregulated in G2
(Lew and Reed, 1993). Cdc6 may therefore directly or
indirectly inhibit the mitotic Cdc28 kinases. We ob-
served that in vitro Cdc6 directly inhibited phosphor-
ylation of histone Hi by Cdc28 kinase prepared with
either p13-agarose (our unpublished observations) or
HA-Clb2 immunoprecipitates (Figure 6E). Because
Cdc6 is also a substrate of B-type cyclin/Cdc28, the
inhibition seen here may be competitive and therefore
only of physiological significance when the Cdc6 pro-
tein is present in excess (see DISCUSSION). However,
as shown below (Figure 8), the levels of Cdc6 used to
inhibit the HA-Clb2 immunoprecipitates (Figure 6E)
are only slightly higher than the levels of p405sc1 re-
quired to inhibit HA-Clb5 immunoprecipitates under
the conditions of our assays.
p40scl Inhibits the Association of Clb5,6/Cdc28 and
Cdc6 In Vivo and In Vitro
Because both Cdc6 and Clb5,6 are required for the
initiation of replication (Epstein and Cross, 1992; Ri-
chardson et al., 1992; Kuhne and Linder, 1993; Schwob
and Nasmyth, 1993), we have investigated their asso-
ciation in greater detail. B-type cyclin-dependent ki-
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nases are inhibited by p40s"Cl which is expressed in
late mitosis and early Gi (Schwob et al., 1994). In late
Gl, p40sicl is degraded by the CDC34-dependent path-
way (Schwob et al., 1994), leading to activation of
Clb5/Cdc28 kinase. One possible role for the interac-
tion of Cdc6 with Clb5/Cdc28 may be to trigger the
conversion of the inactive origin into an active repli-
cation fork. In this case, p40sicl may serve to prevent
the interaction until the cell is completely prepared for
S phase. To test the effect of intracellular p40 icl levels
on Cdc6/Cdc28 complex formation, we blocked a
A yGST yGST-Cdc6
Clb5 HA-Clb5 Clb5 HA-Clb5
NPT PT NPT Noc NPT PT NPT Noc
1 2 3 4 5 6 7 8
M mom _ - *- yGST-Cdc6
cdc34 strain carrying the HA-tagged CLB5 gene at the
restrictive temperature, and the presence of Clb5 and
its ability to associate with Cdc6 were assessed. Al-
though HA-Clb5 present in asynchronous cultures
A
MBP MBP4Sicl
1 2 3 4 5 6 7 8
-- HA-ClbS
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Figure 7. Clb5/Cdc28 binds to Cdc6 only in the absence of p40SiCl*
The experimental conditions were as in Figure 5. Beads charged
with yGST or yGST-Cdc6 were incubated with extracts expressing
HA-Clb5 and blocked at either the cdc34 step or the Nocodazole step
in the cell cycle. Beads were washed and analyzed by SDS gel
analysis and immunoblotting. (A and C are controls, indicating that
nearly equivalent amounts of material were used in these experi-
ments in B.) (A) Anti-GST immunoblot of yGST protein beads (lanes
1-4) or yGST-Cdc6 beads (lanes 5-8) incubated in various extracts.
Lanes 1 and 5 show extracts of RJD668 (cdc34-2) incubated for 4 h at
the nonpermissive temperature; lanes 2 and 6 show extracts of
JCY61 (cdc34-2, ADH-CLB5-HA; see MATERIALS AND METHODS)
cycling at the permissive temperature; lanes 3 and 7 show extracts
of JCY61 incubated for 4 h at the nonpermissive temperature; lanes
4 and 8 show strain JCY61 arrested with Nocodazole at the permis-
sive temperature. (B) 12CA5 immunoblot of HA-Clb5 protein bound
to bGST and bGST-Cdc6 beads (lanes are the same as in A). (C)
Control 12CA5 immunoblot showing constitutive expression of HA-
Clb5 in all JCY61 extracts.
C
HA-Clb5/Cdc28 PKA
MBP Sicl MBP Sicl
-H istone H
Figure 8. p40s1c' inhibits association of HA-Clb5 and Cdc6. Mal-
tose binding protein (MBP) was fused to p40sicl. MBP and MBP-
p4osicl were expressed in E. coli and purified to homogeneity. The
protein concentration was determined by Bradford analysis. The
purified fusion protein was the gift of Dr. R. Deshaies, California
Institute of Technology. (A) HA-Clb5 extract (0.25 mg) was incu-
bated with increasing amounts of MBP or MBP-p4oSic' (0, 80 ng, 400
ng, and 2 jig). Preincubated extracts were then further incubated
with bGST-Cdc6 beads in the presence of 2 mM ATP for 2 h. Beads
were washed and analyzed for HA-Clb5 binding by protein blotting
with 12CA5 antibody. (B) Inhibition of Clb5/Cdc28 activity
by MBP-p40sicl. HA-Clb5 extract was incubated with MBP and
MBP-p40oicl as in A. HA-Clb5 was immunoprecipitated and as-
sayed for histone Hl kinase activity. Open symbols, MBP; closed
symbols, MBP-p40O-scl. Protein concentration was determined by
Bradford assay. (C) Inhibition of Clb5/Cdc28 by MBP-p40sicl is
specific. Histone HI kinase activity of HA-Clb5 immunoprecipi-
tated from 0.2 mg of extract was assayed in the presence of increas-
ing amounts of MBP (ranging from 0 to 2 ,ug, first set of three lanes)
and increasing amounts of MBP-p40Sicl (ranging from 0 to 2 ,ug,
second set of three lanes). Histone HI kinase activity of protein
kinase A was assayed in the presence of increasing amounts of MBP
(ranging from 0 to 2 ,ug, third set of three lanes) and increasing
amounts of MBP-p405icl (ranging from 0 to 2 jig, fourth set of three
lanes). Products were electrophoresed and autoradiographed. Phos-
phorylated histone HI is indicated.
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Figure 9. Cdc6AN complements a cdc6 null only at elevated levels. Strain K4055 was transformed with plasmids YGp618 and pSE19,
expressing GAL-CDC6 and GAL-cdc6AN protein, respectively. The plasmid YGp1O, carrying the GAL1,10 promoter only, was used as a
control. Transformants were streaked onto medium either lacking or containing 2 mM methionine and containing 2% dextrose and 2%
galactose (GAL-repressing conditions) or 2% raffinose and 2% galactose (GAL-inducing conditions). Plates were incubated at 30°C for 3 d and
then photographed.
was able to bind to Cdc6, HA-Clb5 present in cdc34-
arrested cells, which cannot degrade p40sic1 and there-
fore contain high levels of p40s5c1, did not bind (Figure
7). In contrast, in cells arrested in G2 with Nocodazole,
where p4Osi" is absent, HA-Clb5/Cdc28 did associate
with Cdc6 (Figure 7). This suggested that p4Os'c' not
only inhibits the kinase activity of Clb5/Cdc28 but
also inhibits the association of Clb5/Cdc28 with Cdc6.
To establish that the lack of binding in the cdc34-
arrested cells was due to p4Osi', we purified a maltose
binding protein (MBP)-p4Osicl fusion protein (Figure
8, legend). As shown in Figure 8B, the fusion protein
was active in inhibiting Clb5/Cdc28 histone Hi kinase
activity and also inhibited the association of Clb5/
Cdc28 with the yGST-Cdc6 beads (Figure 8A). As a
control for the specificity of the inhibition, protein
kinase A was shown to be resistant to inhibition by the
MBP-p4OSicl fusion protein (Figure 8C). Therefore,
Clb5/Cdc28 does not bind to Cdc6 in the presence of
p4Os"', and binding in vivo, therefore, probably oc-
curs after degradation of p40S'cl.
Effect of Deletion of the N-Terninal 47 Amino Acids
from CDC6
We showed above that the 47 N-terminal amino acids
of CDC6 are sufficient for interaction between Cdc6
and Cdc28. To evaluate the specific role of the Cdc28/
Cdc6 interaction in vivo, we deleted the first 47 amino
acids of CDC6. The phenotype of cells expressing
only this cdc6AN mutant was evaluated by a
MET3-CDC6::TRP1cdc6A strain. In the presence of me-
thionine, this strain will grow only if a functional copy
of CDC6 is provided on a plasmid. Because the levels
of Cdc6 protein are regulated dramatically in the cell
cycle (Piatti et al., 1995) and because the N-terminal 47
amino acids contain a PEST sequence that could be
important for such regulation, we examined the ability
of cdc6AN to complement the methionine-repressed
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Figure 10. Overproduction of full-length, but
not cdc6AN, protein perturbs cell growth and
morphology. Colonies were picked from plates
pictured in Figure 9, and cells were photo-
graphed under a light microscope. In left panel,
K4055 transformed with pSE19, GAL-cdc6AN,
and grown on medium with 2 mM methionine,
2% raffinose, and 2% galactose. In right panel,
K4055 transformed with YGp618, GAL-CDC6,
and was grown on the same medium.
4
.%c ^" I -
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GAL-cdc6AN
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host not only under the control of the native promoter
but also under several different expression regimes.
When expressed from the GAL promoter on medium
containing glucose plus galactose, the wild-type GAL-
CDC6 gene supported growth of the MET-CDC6 strain
in the presence of methionine (Figure 9). In contrast,
the GAL-cdc6AN mutant did not support growth un-
der these growth conditions. GAL-cdc6AN also failed
to support growth on the nonrepressing carbon source
raffinose (our unpublished observations), whereas the
wild type supported growth at normal rates. Assum-
ing that both mutant and wild-type proteins are tran-
scribed and translated at the same level, a reasonable
assumption given our experience with the GST-tagged
constructs, these experiments suggest that the cdc6AN
mutant is defective in some essential function of Cdc6.
A different result was obtained after induction of
GAL-CDC6 and GAL-cdc6AN with galactose. The over-
produced cdc6AN protein is capable of supporting
growth, suggesting that cdc6AN is less efficient than
Cdc6 at promoting DNA replication but can do so
when present in excess. What is interesting in addition
is that overproduction of wild-type CDC6 leads to
slow growth and bud hyperpolarization, as originally
reported by others (Bueno and Russell, 1992), but
overproduction of cdc6AN results in growth at normal
rates, and the cells show normal morphology (Figure
10). It has been proposed that overproduction of wild-
type Cdc6 leads to restraint of mitosis, and the results
shown in Figure 10 suggest that the Cdc6/Cdc28 in-
teraction is important for this inhibition of mitosis.
When CDC6 and cdc6AN were expressed under con-
trol of the CDC6 promoter, cdc6AN supported growth
at the same rate as wild type. Sufficient cdc6AN must
be produced under these expression conditions so that
initiation can occur. It may be the case that cdc6AN is
present at elevated levels because of the lack of the
complete putative PEST sequence.
DISCUSSION
The yeast replication cycle model proposed recently
on the basis of genetic and physiological experiments
posits that Clb5/Cdc28 is required both for activation
of replication origins in Gl and for inhibition of reac-
tivation of origins in S, G2, and M (Dahmann et al.,
1995; Piatti et al., 1996). We have now shown that Cdc6
has all the right properties to be a critical target of
Clb5/Cdc28 regulation. Cdc6 associates stably with
Cdc28 in vivo. Cdc6 binds preferentially to Clb rather
than Cln/Cdc28 complexes (see Figure 5), and the two
proteins are not associated before the CDC34-depen-
dent step is completed in Gi, presumably because of
inhibition by p40S'cl (see Figure 8). That the associa-
tion of the Cdc6 and Cdc28 kinase is physiologically
important is demonstrated by the effect of deleting the
Cdc28-interacting domain from the Cdc6 protein. At
low levels of expression, where wild-type Cdc6 sup-
ports cellular growth, the mutant fails to form colo-
nies. At high levels of expression, the mutant can
support growth. Thus, the mutant protein is less effi-
cient than wild-type Cdc6 in promoting cell growth. In
addition, the inhibition of growth and bud hyperpo-
larization seen when wild type is overexpressed is not
observed, suggesting that the Cdc28 interaction do-
main has an important role restraining mitosis and,
thus, in ordering DNA replication and mitosis.
A model incorporating our results and those of oth-
ers is shown in Figure 11. In vivo footprinting of ARSs
has suggested that yeast replication origins alternate
between at least two different states (Diffley et al.,
1994). During late mitosis and early Gi, origins are in
a prereplicative state primed for initiation. Upon ori-
gin activation at G1 /S, ARSs are converted to a post-
replicative state, which is refractory to re-initiation
and persists through S, G2, and part of M. The post-
replicative complex (post-RC) consists of ORC and
ABF1 (Diffley et al., 1994). Resetting to the prereplica-
tive complex (pre-RC) occurs late in mitosis coincident
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Figure 11. The Cdc6 cycle. After the mitotic cyclins are degraded in late mitosis, Cdc6 binds to ORC at replication origins in a step required
to recruit additional replication proteins, such as MCMs, to the origins for initiation (formation of the pre-RC; Diffley et al., 1994). In Gl, p40sic1
binds to Clb5/Cdc28 (Schwob et al., 1994), preventing the kinase from binding to Cdc6. When p4Os'c' is degraded by the CDC34-dependent
pathway in late Gl, Clb5/Cdc28 associates with Cdc6 in the pre-RC and perhaps with other components as well. This leads to origin
activation, dissociation of Cdc6, and conversion of pre-RCs to post-RCs. (Post-RCs are found at this earliest portion of S phase.) At this time
and until mitosis, Cdc6 is prevented from reassociating with the origin through interaction with B-type cyclin/Cdc28. This interaction may
lead to degradation, sequestration, or inactivation of an activity of Cdc6 (Nishitani and Nurse, 1995; Piatti et al., 1995). Cdc6/cyclin B/Cdc28
might also form a signal for preventing mitosis In late mitosis, cyclins are degraded, and CDC6 mRNA and protein accumulate; Cdc6 binds
to ORC to form the pre-RC and primes the origin for the next round of replication.
with the time of cyclin B degradation, p4Os'c' expres-
sion, and Cdc6 expression (Diffley et al., 1994; Dono-
van et al., 1994; Piatti et al., 1995). It is likely that a key
step in the transition involves recruitment of Cdc6 into
the ORC/ABF1 complex, because formation of pre-
RCs requires Cdc6, because pre-RCs are thermolabile
in cdc6ts mutants, and because Cdc6 both shows ge-
netic interactions with ORC and interacts stably with
ORC in vitro (Li and Herskowitz, 1993; see Figure 5,
Diffley et al., 1994; Liang et al., 1995; Cocker et al., 1996).
Cdc6 may, in turn, recruit other replication proteins,
such as the MCM family (Yan et al., 1993). Three key
observations suggest that the putative recruitment of
Cdc6 into the pre-RC is regulated by cyclin B/Cdc28.
First, formation of the pre-RC can be brought about by
premature expression in G2 of the Clb5/Cdc28 inhib-
itor p4Os'cl. Second, in siml and sim2 mutants, which
undergo a second round of replication when arrested
in G2, cyclin B/Cdc28 kinase levels are very low, and
overproduction of Clb5, rather than stimulating initi-
ation, actually prevents re-replication (Dahmann et al.,
1995). Third, there exists a "point of no return" in Gl,
after which Cdc6 cannot be recruited into the pre-RC;
this point of no return coincides temporally with the
degradation of p40sc' and activation of Clb5/Cdc28
(Piatti et al., 1996). Our demonstration that Cdc6 inter-
acts biochemically with Clb5/Cdc28 and that the in-
teraction is inhibited by p40sicl, which has now also in
part been shown by others (Piatti et al., 1996), suggests
that Cdc6 is a target of Clb5/Cdc28 and that Clb5/
Cdc28 inhibits Cdc6 recruitment into the pre-RC. The
cdc6AN mutant we describe (see Figure 9) may be able
to function when present in excess, but not at lower
levels, because there is a longer window for formation
of the pre-RC, continuing even after activation of
Clb5/Cdc28 and providing time for a less efficient
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activator to function. Only after cyclin B degradation
and p4Osc' expression late in mitosis can the pre-RC
form. Our results taken together argue for a post-
translational role for the kinase/Cdc6 interaction
rather than for indirect effects on Cdc6 mRNA expres-
sion. A prediction of this model is that Cdc6 binding to
Clb5/Cdc28 should prevent binding of Cdc6 to the
ORC/ARS complex.
The proteins in the pre-RC are poised for origin
firing, but initiation requires further activation in Gl
by S-phase-promoting factors. Both Cdc7/Dbf4 ki-
nase (Rowley et al., 1995) and Clb5,6/Cdc28 kinase
(Schwob and Nasmyth, 1993) are required and prob-
ably phosphorylate proteins in the pre-RC, such as
ORC (Leatherwood et al., 1996). The interaction of
Clb5/Cdc28 with Cdc6 in late Gl may also be a key
step in origin activation, because deletion of the Cdc28
interaction domain leads to defects in growth. A sud-
den conversion of the pre-RC into the post-RC (which
seems to contain ORC but not Cdc6) is observed at the
beginning of S phase and is thought to coincide with
origin activation. Interaction of Cdc6 with Clb5/
Cdc28, which occurs only after p40sc degradation,
might lead to the transition. Phosphorylation may or
may not be required. Clb5/Cdc28 might extract Cdc6
from the complex with ORC and sequester the Cdc6 or
target it for degradation. The latter model is attractive,
because Cdc6 protein has a short half-life. However,
degradation of Cdc6 has not yet been shown to be
essential for entry into S phase (Piatti et al., 1996). In
this way, activation of Clb5/Cdc28 might lead not
only to firing of primed origins, perhaps by relieving
some inhibitory function of Cdc6, but also to suppres-
sion of de novo pre-RC formation both immediately
after origin duplication and until cyclin B destruction
at mitosis. Interaction of Cdc6 with Clb5/Cdc28 could
therefore account for once and only once replication
and preservation of the order of replication and seg-
regation of chromosomes, i.e., prevention of re-repli-
cation without an intervening mitosis.
When constitutively expressed at high levels, Cdc6
can transiently inhibit mitosis (Bueno and Russell,
1992) and slow the growth of yeast (this work). Our
demonstration that high levels of Cdc6 inhibit Clb2/
Cdc28 (see Figure 6) in vitro could account for the G2
delay observed when Cdc6 is overproduced and
therefore present in excess or for a long time. Levels of
Cdc6 we observe in vivo after 4 h of expression are
comparable to concentrations used in our assays. Dur-
ing normal cell cycles, Cdc6 is not likely to regulate the
G2/M transition by such direct inhibition, primarily
because Cdc6 levels are either quite low or absent at
this phase of the cell cycle. Other observations, how-
ever, suggest that Cdc6 at normal concentrations may
play a more indirect role in restraining mitosis. Rao
and Johnson (1970) showed that, when a G2 cell is
fused to an S-phase cell, the G2 nucleus does not enter
mitosis until the S-phase nucleus has also completed
DNA synthesis and traversed G2 (Rao and Johnson,
1970). It has been proposed that cells in S phase gen-
erate a signal that restrains mitosis. The Cdc6/cyclin
B/Cdc28 complex might constitute such a signal. The
difference between the phenotype of cells overexpress-
ing wild-type CDC6 and the cdc6AN truncation mu-
tant that does not interact with Cdc28 supports this
idea (see Figure 10). Therefore, destruction of Cdc6
may be required for entry into mitosis.
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